Skip to main content
. 2022 Dec 2;14(12):2699. doi: 10.3390/pharmaceutics14122699

Figure 2.

Figure 2

Summary of EV-based platforms for tissue-specific mRNA expression. (A) miRNA-dependent mRNA expression. (B) Ultrasound assisted delivery. (C) Targeting peptide-based fusion protein. (D) Lactadherin–phosphatidylserine interaction. (E) Enzymatic covalent conjugation. IRES, internal ribosome entry site; RVG, rabies viral glycoprotein; ATS, adipocyte-targeting sequence; scFv, single chain variable fragment; LLS, lactadherin leader sequence; Ce6, sonosensitizer chlorin e6; ROS, reactive oxygen species; PS, phosphatidylserine; TK, thioketal.